Back Pain in Chattem Inc Drugs

9 drug(s) with this reaction

2,066 total reports

Overview

Back Pain has been reported as an adverse reaction across 9 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,066 adverse event reports mention back pain in connection with Chattem Inc products.

This page provides a breakdown of which Chattem Inc drugs are most commonly associated with back pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.

Chattem Inc Drugs Reporting Back Pain

The following Chattem Inc drugs have back pain listed in their FDA adverse event reports, sorted by report count:

Other Reactions Reported for Chattem Inc Drugs

In addition to back pain, the following adverse reactions have been reported across Chattem Inc's drug portfolio:

DRUG INEFFECTIVEHEADACHEFATIGUENAUSEAPRURITUSEXTRA DOSE ADMINISTEREDDIARRHOEANO ADVERSE EVENTDIZZINESSRASHSOMNOLENCEDYSPNOEACOUGHINSOMNIAPAINFEELING ABNORMALOFF LABEL USEMALAISECONDITION AGGRAVATEDPRODUCT DOSE OMISSION ISSUE

Frequently Asked Questions

Which Chattem Inc drugs cause Back Pain?

9 drug(s) manufactured by Chattem Inc have back pain listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, MENTHOL, DOXYLAMINE SUCCINATE, and others.

How many Back Pain reports are there for Chattem Inc drugs?

There are a combined 2,066 reports of back pain across 9 Chattem Inc drug(s) in the FDA adverse event database.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.